Esa Medika Mandiri Tbk. vs Merck Tbk. — how do they compare? Esa Medika Mandiri Tbk. trades at Rp344 (market cap 623.94B, 3.05M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 2.8× Esa Medika Mandiri Tbk.'s market cap, and Esa Medika Mandiri Tbk. is more actively traded (3.05M versus 29.1K). Which is the better fit depends on your goals.
| EMMI | MERK | |
|---|---|---|
Market Cap | 623.94B | 1.75T |
Volume | 3.05M | 29.1K |
Lot | 30.45K | 291 |
Turnover | 1.06B | 113.37M |
Average Price | 348.12 | 3,895.98 |
Value | 1.06B | 113.37M |
Indicative Equilibrium Price | 344 | 3,890 |
Indicative Equilibrium Volume | 1.77K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Read more on EMMI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →